Get the Stockscreener App
3.65
0.82%
-0.03
After Hours:
3.69
0.04
+1.10%
Sonoma Pharmaceuticals Inc stock is traded at $3.65, with a volume of 7,937.
It is down -0.82% in the last 24 hours and down -9.65% over the past month.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
See More
Previous Close:
$3.68
Open:
$3.67
24h Volume:
7,937
Relative Volume:
0.01
Market Cap:
$6.00M
Revenue:
$14.91M
Net Income/Loss:
$-3.56M
P/E Ratio:
-1.4842
EPS:
-2.4593
Net Cash Flow:
$-1.37M
1W Performance:
-3.44%
1M Performance:
-9.65%
6M Performance:
+15.87%
1Y Performance:
+30.36%
1-Day Range:
$3.6001
$3.72
1-Week Range:
$3.37
$3.875
52-Week Range:
$1.75
$6.9199
Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile
Name
Sonoma Pharmaceuticals Inc
Sector
Phone
800-759-9305
Address
5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
Compare SNOA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNOA
Sonoma Pharmaceuticals Inc
|
3.65 | 6.26M | 14.91M | -3.56M | -1.37M | -2.4593 |
|
ZTS
Zoetis Inc
|
119.79 | 52.99B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.71 | 43.15B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.57 | 42.12B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.26 | 27.50B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
453.93 | 19.33B | 3.08B | 1.24B | 1.07B | 25.61 |
Sonoma Pharmaceuticals Inc Stock (SNOA) Latest News
Is Sonoma Pharmaceuticals Inc. stock in correction or buying zone2025 Technical Overview & Low Volatility Stock Recommendations - newser.com
Sentiment analysis tools applied to Sonoma Pharmaceuticals Inc.July 2025 Earnings & Smart Money Movement Alerts - newser.com
Intraday pattern recognizer results for Sonoma Pharmaceuticals Inc.Market Volume Summary & AI Enhanced Trading Alerts - newser.com
How analysts revise price targets for Sonoma Pharmaceuticals Inc. (O8Z) stockEarnings Risk Summary & Weekly High Conviction Trade Ideas - newser.com
Sonoma Pharmaceuticals, Inc. (SNOA) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Sonoma Pharmaceuticals: A Turning Point as Quarterly Results Show Dramatic Growth - AD HOC NEWS
Sonoma Pharmaceuticals Inc. stock volume spike explained2025 Year in Review & Smart Allocation Stock Reports - newser.com
What does recent volatility data suggest for Sonoma Pharmaceuticals Inc.Analyst Upgrade & Reliable Intraday Trade Alerts - newser.com
Why Sonoma Pharmaceuticals Inc. stock is favored by top institutionsJobs Report & Free AI Powered Buy and Sell Recommendations - newser.com
Does Sonoma Pharmaceuticals Inc. stock trade at a discount to peers2025 EndofYear Setup & Precise Swing Trade Alerts - newser.com
Predicting Sonoma Pharmaceuticals Inc. trend using moving averagesJuly 2025 Action & Daily Profit Focused Stock Screening - newser.com
Sonoma Pharmaceuticals reports higher revenue - Boulder Daily Camera
Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf - ACCESS Newswire
Sonoma Pharmaceuticals (Nasdaq: SNOA) to Exhibit at MEDICA 2025, showcasing Microcyn HOCl - Stock Titan
Will Sonoma Pharmaceuticals Inc. stock attract more institutional investors2025 Stock Rankings & Safe Entry Trade Reports - newser.com
How Sonoma Pharmaceuticals Inc. (O8Z) stock responds to job market shiftsEarnings Beat & Risk Controlled Swing Trade Alerts - newser.com
Is Sonoma Pharmaceuticals Inc. stock gaining market shareJuly 2025 Earnings & Fast Moving Stock Watchlists - newser.com
Will Sonoma Pharmaceuticals Inc. stock attract ESG investorsJuly 2025 Breakouts & Community Driven Trade Alerts - Fundação Cultural do Pará
How Sonoma Pharmaceuticals Inc. stock reacts to oil pricesEarnings Overview Report & Growth Focused Stock Reports - Fundação Cultural do Pará
Will Sonoma Pharmaceuticals Inc. (O8Z) stock rise with strong economyJuly 2025 Trends & Stepwise Trade Signal Guides - newser.com
How to interpret RSI for Sonoma Pharmaceuticals Inc. stockJuly 2025 Levels & Technical Entry and Exit Tips - newser.com
Is Sonoma Pharmaceuticals Inc. stock a buy for dividend growthEarnings Summary Report & High Accuracy Buy Signal Tips - newser.com
What downside risks could hit Sonoma Pharmaceuticals Inc. (O8Z) stockJuly 2025 WrapUp & Weekly Sector Rotation Insights - newser.com
Analyzing net buyer seller activity in Sonoma Pharmaceuticals Inc.Earnings Trend Report & Safe Capital Growth Trade Ideas - newser.com
Sonoma Pharmaceuticals Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Can Sonoma Pharmaceuticals Inc. (O8Z) stock sustain margin levelsWeekly Investment Summary & Fast Exit and Entry Trade Guides - newser.com
What Analyst Watch Lists Suggest About JK Agri Genetics Limiteds MomentumStock Buyback Announcements & Affordable Growth Investments - earlytimes.in
What analysts say about Sonoma Pharmaceuticals Inc stockSwing Trading Ideas & Free Superior Stock Performance - earlytimes.in
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results - ACCESS Newswire
Sonoma Pharmaceuticals Q2 revenue beats expectations on increased distributor sales - MarketScreener
Sonoma Pharmaceuticals, Inc. SEC 10-Q Report - TradingView
Earnings Recap: How Sonoma Pharmaceuticals Inc. stock reacts to oil pricesJuly 2025 Market Mood & Weekly Chart Analysis and Trade Guides - Fundação Cultural do Pará
Sonoma Pharmaceuticals Inc expected to post a loss of 31 cents a shareEarnings Preview - TradingView
Sonoma Pharmaceuticals Inc Stock (SNOA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
1.54%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):